Analysts

Firm Analyst
Cantor Fitzgerald Charles Duncan, Ph.D.
Cowen and Company Phil Nadeau, Ph.D.
Goldman Sachs Salveen Richter
H.C. Wainwright Raghuram Selvaraju, Ph.D.
Jefferies LLC Michael Yee
J.P. Morgan Cory Kasimov
Oppenheimer & Co. Jay Olson
Stifel Paul Matteis
Wedbush Laura Chico, Ph.D.

Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Quote

ACOR (Common Stock) $ 3.12 -0.06 (-1.89%) Volume: 1,225,586 MORE August 23, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.